| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | SB INVESTMENT ADVISERS (UK) LTD | 65.93M (18.45%) | -5.43M Decreased by -8.23% | Sep 30, 24 |
| 2 | Qvt Financial LP | 65.79M (18.41%) | -926.00K Decreased by -1.41% | Sep 30, 24 |
| 3 | Viking Global Investors LP | 54.10M (15.13%) | -15.06M Decreased by -27.83% | Sep 30, 24 |
| 4 | FMR Inc | 49.15M (13.75%) | 2.59M Increased by +5.28% | Sep 30, 24 |
| 5 | Vanguard Group Inc | 41.68M (11.66%) | 33.49M Increased by +80.35% | Sep 30, 24 |
| 6 | BlackRock Inc | 35.37M (9.90%) | -817.25K Decreased by -2.31% | Jun 30, 24 |
| 7 | Morgan Stanley - Brokerage Accounts | 29.67M (8.30%) | -28.99M Decreased by -97.68% | Sep 30, 24 |
| 8 | Rubric Capital Management LP | 22.40M (6.27%) | -600.00K Decreased by -2.68% | Sep 30, 24 |
| 9 | State Street Corp | 19.56M (5.47%) | 1.12M Increased by +5.72% | Sep 30, 24 |
| 10 | State Street Corporation | 17.15M (4.80%) | 3.43M Increased by +19.97% | Mar 31, 24 |
| 11 | Wellington Management Company LLP | 13.64M (3.82%) | -1.20M Decreased by -8.82% | Dec 31, 23 |
| 12 | Patient Square Capital | 12.23M (3.42%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 13 | T. Rowe Price Investment Management,Inc. | 10.65M (2.98%) | 10.65M Increased by +100.00% | Sep 30, 23 |
| 14 | Two Seas Capital LP | 9.72M (2.72%) | -593.87K Decreased by -6.11% | Sep 30, 24 |
| 15 | Woodline Partners LP | 8.69M (2.43%) | 685.54K Increased by +7.89% | Sep 30, 24 |
| 16 | Geode Capital Management, LLC | 7.75M (2.17%) | 1.46M Increased by +18.85% | Sep 30, 24 |
| 17 | Baker Bros Advisors LP | 7.41M (2.07%) | -179.19K Decreased by -2.42% | Mar 31, 24 |
| 18 | Farallon Capital Management, L.L.C. | 7.34M (2.05%) | 3.48M Increased by +47.47% | Dec 31, 23 |
| 19 | Amvescap Plc. | 6.36M (1.78%) | 447.39K Increased by +7.04% | Sep 30, 24 |
| 20 | Citadel Advisors Llc | 5.93M (1.66%) | 4.00M Increased by +67.54% | Sep 30, 24 |
| Rank | Holder | SharesFloat % | Change | Date reported |
|---|---|---|---|---|
| 1 | Fidelity Growth Compy Commingled Pl S | 21.59M (6.04%) | 443.75K Increased by +2.06% | Sep 30, 24 |
| 2 | Fidelity Growth Compy Commingled Pl O | 21.15M (5.92%) | 439.20K Increased by +2.08% | Aug 31, 24 |
| 3 | Fidelity Growth Company Fund | 15.78M (4.41%) | 219.66K Increased by +1.39% | Sep 30, 24 |
| 4 | iShares Core S&P Mid-Cap ETF | 14.01M (3.92%) | 27.49K Increased by +0.20% | Nov 27, 24 |
| 5 | Vanguard Total Stock Mkt Idx Inv | 14.00M (3.92%) | -40.70K Decreased by -0.29% | Oct 31, 24 |
| 6 | Vanguard Small Cap Index | 11.13M (3.11%) | 21.78K Increased by +0.20% | Oct 31, 24 |
| 7 | Fidelity® Growth Company | 10.84M (3.03%) | 288.60K Increased by +2.66% | Nov 30, 23 |
| 8 | Vanguard Health Care Inv | 9.57M (2.68%) | 0.00 Increased by 0.00% | Dec 31, 23 |
| 9 | SPDR® S&P Biotech ETF | 7.19M (2.01%) | -218.43K Decreased by -3.04% | Nov 27, 24 |
| 10 | Vanguard Institutional Extnd Mkt Idx Tr | 6.42M (1.80%) | -22.72K Decreased by -0.35% | Oct 31, 24 |
| 11 | Vanguard Small Cap Growth Index Inv | 6.12M (1.71%) | -14.21K Decreased by -0.23% | Oct 31, 24 |
| 12 | T. Rowe Price Mid-Cap Growth | 5.25M (1.47%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 13 | T. Rowe Price US Mid-Cap Growth Equity | 5.25M (1.47%) | 5.25M Increased by +100.00% | Sep 30, 23 |
| 14 | Fidelity Growth Company K6 | 5.22M (1.46%) | -13.82K Decreased by -0.26% | Sep 30, 24 |
| 15 | Invesco S&P MidCap Quality ETF | 4.75M (1.33%) | 5.63K Increased by +0.12% | Nov 27, 24 |
| 16 | Fidelity® Select Biotechnology | 4.60M (1.29%) | 61.10K Increased by +1.33% | Nov 30, 23 |
| 17 | Fidelity Series Growth Company | 4.20M (1.17%) | 200.90K Increased by +4.78% | Sep 30, 24 |
| 18 | Fidelity® Growth Company K6 | 3.63M (1.02%) | -389.86K Decreased by -10.74% | Nov 30, 23 |
| 19 | MS INVF US Advantage I | 3.62M (1.01%) | 0.00 Increased by 0.00% | Sep 30, 24 |
| 20 | Polar Capital Biotech S Inc | 3.50M (0.98%) | 0.00 Increased by 0.00% | Oct 31, 24 |